Trends and disparities in herpes zoster vaccination coverage among US adults with cardiovascular disease
Authors:
- Chieh-Yu HoCHChieh-Yu Ho
- Chun-Tse HungCHChun-Tse Hung
- Hsin-Yi HuangHHHsin-Yi Huang
- Chung-Hsuen WuCWChung-Hsuen Wu
- 30 September 2026
- journal article
- Published by Elsevier in American Journal of Infection Control
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Pharmacy‐Based Immunization Delivery: A Comprehensive History and Current ChallengesJACCP: Journal of the American College of Clinical Pharmacy, 2026
- Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complicationseClinicalMedicine, 2025
- National trends and disparities in herpes zoster vaccination among US older adults with chronic obstructive pulmonary disease, 2008 to 2022American Journal of Infection Control, 2024
- The impact of pharmacist involvement on immunization uptake and other outcomes: An updated systematic review and meta-analysisJournal of the American Pharmacists Association, 2022
- Factors influencing series completion rates of recombinant herpes zoster vaccine in the United States: A retrospective pharmacy and medical claims analysisJournal of the American Pharmacists Association, 2022
- Racial/Ethnic and Socioeconomic Disparities in Adult Vaccination CoverageAmerican Journal of Preventive Medicine, 2021
- Diabetes as a risk factor for herpes zoster in adults: A synthetic literature reviewDiabetes Research and Clinical Practice, 2020
- Disaggregating ethnoracial disparities in physician trustSocial Science Research, 2015
- Use of Low-Dose Aspirin as Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults (from the National Health Interview Survey, 2012)The American Journal of Cardiology, 2015
- Self-report compared to electronic medical record across eight adult vaccines: Do results vary by demographic factors?Vaccine, 2013